Company news
Ai, Inc. (TSE:4388) news
Ai, Inc. news releases on 6ix. Latest, May 21, 2026: Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital…
Press releases & updates
Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use
May 21, 2026
Tempus to Host Inaugural Investor Day on May 29, 2026
April 29, 2026
Tempus to Report First Quarter 2026 Financial Results on May 5
April 21, 2026
Zephyr AI Appoints Dr. Lisa Eli as Chief Scientific Officer
April 21, 2026
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026
April 14, 2026
Tempus Launches Automated "Active Follow-Up" Service to Support Guideline-Concordant Care
April 13, 2026
Magna AI and Corvit Networks Forge Strategic Alliance to Accelerate Pakistan’s National AI Development
April 9, 2026
Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
April 1, 2026
Tempus Announces Strategic Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Clinical Differentiation Across an ADC Clinical Program
March 25, 2026
Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
March 11, 2026
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
February 26, 2026
Tempus Reports Fourth Quarter and Full Year 2025 Results
February 24, 2026
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
February 18, 2026
Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform
February 12, 2026
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers
January 27, 2026
Tempus Announces the Launch of Paige Predict
January 21, 2026
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
January 11, 2026
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 11, 2026
Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium
January 8, 2026
Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
MetaGuard AI Debuts Defense-Grade Cybersecurity Platform at CES 2026 with Industry-First Full Source Code Access and BrainChip Neuromorphic Support
January 2, 2026
Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium
December 9, 2025
SHARON AI Appoints Mr Ross Barrows As Head of Capital Strategy & Investor Relations
December 3, 2025
SHARON AI To Appoint Mr Drew Kelton To Board of Directors
December 1, 2025
SHARON AI’s 1GW+ Data Center Campus Joint Venture Acquires Additional 203 Contiguous Acres
November 24, 2025
Tempus Reports Third Quarter 2025 Results
November 4, 2025
Tempus to Participate in the Stifel 2025 Healthcare Conference
October 28, 2025
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
October 16, 2025
Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
October 15, 2025
Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
October 9, 2025
SHARON AI Initiates Phase Two Engineering for Its Flagship 1GW AI Data Center Campus Joint Venture in Texas
October 8, 2025
Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer
September 9, 2025
Tempus to Participate in Morgan Stanley’s 23rd Annual Global Healthcare Conference
September 3, 2025
Zephyr AI Appoints Watson Pharmaceuticals Founder Dr. Allen Chao as Chief Executive Officer
August 26, 2025
Tempus Announces the Acquisition of Paige
August 22, 2025
Tempus Reports Second Quarter 2025 Results
August 8, 2025
Unbiased Hiring Decisions with the HiringBranch Soft Skills AI Assessment
May 28, 2025
Assert AI Welcomes Arun Harihara Subramony as Strategic Industry Advisor to Strengthen Focus on Manufacturing and Energy sectors
January 20, 2025
Skylark AI Launches Purpose-Built AI Engine to Revolutionize Private Investment Analysis and Enterprise AI Deployment
November 20, 2024
Robot 1000 AI INC Introduces Breakthrough AI-Driven Forex Trading Platform
July 23, 2024